- Home
- ZBH
as 12-18-2024 1:44pm EST
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
| Founded: | 1927 | Country: | United States |
| Employees: | N/A | City: | WARSAW |
| Market Cap: | 20.8B | IPO Year: | N/A |
| Target Price: | $123.63 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Hold | Number of Analysts: | 21 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.26 | EPS Growth: | 132.72 |
| 52 Week Low/High: | $101.47 - $133.90 | Next Earning Date: | 02-06-2025 |
| Revenue: | $7,595,500,000 | Revenue Growth: | 4.35% |
| Revenue Growth (this year): | 4.76% | Revenue Growth (next year): | 4.63% |
Latest Zimmer Biomet Holdings Inc. News
ZBH Breaking Stock News: Dive into ZBH Ticker-Specific Updates for Smart Investing
MT Newswires
5 hours ago
Truist Securities Adjusts Price Target on Zimmer Biomet to $118 From $117, Keeps Hold Rating
Simply Wall St.
5 hours ago
Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago
MT Newswires
6 hours ago
RBC Raises Price Target on Zimmer Biomet Holdings to $130 From $125, Keeps Outperform Rating
PR Newswire
7 hours ago
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
Thomson Reuters StreetEvents
12 hours ago
Q4 2024 Neuroone Medical Technologies Corp Earnings Call
The Fly
a day ago
Tesla upgraded, MongoDB initiated: Wall Street's top analyst calls
MT Newswires
a day ago
JPMorgan Upgrades Zimmer Biomet to Overweight From Neutral, Adjusts Price Target to $128 From $125
Zacks
2 days ago
ZBH Stock Might Rise Following FDA Nod for OsseoFit
Compare ZBH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZBH Zimmer Biomet Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.